MNOV
Price:
$2.06
Market Cap:
$101.04M
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of ...[Read more]
Industry
Biotechnology
IPO Date
2006-12-08
Stock Exchange
NASDAQ
Ticker
MNOV
According to MediciNova, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.81. This represents a change of 76.73% compared to the average of -5.55 of the last 4 quarters.
The mean historical PE Ratio of MediciNova, Inc. over the last ten years is -14.81. The current -9.81 PE Ratio has changed 6.52% with respect to the historical average. Over the past ten years (40 quarters), MNOV's PE Ratio was at its highest in in the September 2024 quarter at -0.01. The PE Ratio was at its lowest in in the December 2018 quarter at -411.57.
Average
-14.81
Median
-14.86
Minimum
-22.90
Maximum
-7.15
Discovering the peaks and valleys of MediciNova, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.60%
Maximum Annual PE Ratio = -7.15
Minimum Annual Increase = -44.39%
Minimum Annual PE Ratio = -22.90
Year | PE Ratio | Change |
---|---|---|
2023 | -8.58 | 20.10% |
2022 | -7.15 | -44.39% |
2021 | -12.85 | -23.79% |
2020 | -16.86 | -24.98% |
2019 | -22.48 | -1.83% |
2018 | -22.90 | 12.43% |
2017 | -20.36 | 11.25% |
2016 | -18.31 | 71.60% |
2015 | -10.67 | 34.07% |
2014 | -7.96 | -27.63% |
The current PE Ratio of MediciNova, Inc. (MNOV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.53
5-year avg
-13.58
10-year avg
-14.81
MediciNova, Inc.’s PE Ratio is less than Aerovate Therapeutics, Inc. (-0.89), less than Adagene Inc. (-2.76), less than Acrivon Therapeutics, Inc. Common Stock (-3.07), less than Rezolute, Inc. (-4.38), less than AN2 Therapeutics, Inc. (-0.66), less than Eliem Therapeutics, Inc. (0), less than Molecular Partners AG (0), less than Champions Oncology, Inc. (-2.46), greater than Cyteir Therapeutics, Inc. (-185.27), less than Anebulo Pharmaceuticals, Inc. (-9.12), less than PMV Pharmaceuticals, Inc. (-4.94), less than Pharvaris N.V. (-1.47), less than PepGen Inc. (-7.31), less than null (-1.48),
Company | PE Ratio | Market cap |
---|---|---|
-0.89 | $75.07M | |
-2.76 | $88.76M | |
-3.07 | $193.05M | |
-4.38 | $252.05M | |
-0.66 | $40.34M | |
0 | $342.68M | |
0 | $195.74M | |
-2.46 | $112.63M | |
-185.27 | $108.71M | |
-9.12 | $39.16M | |
-4.94 | $75.81M | |
-1.47 | $1.01B | |
-7.31 | $129.08M | |
-1.48 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediciNova, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MediciNova, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MediciNova, Inc.'s PE Ratio?
How is the PE Ratio calculated for MediciNova, Inc. (MNOV)?
What is the highest PE Ratio for MediciNova, Inc. (MNOV)?
What is the 3-year average PE Ratio for MediciNova, Inc. (MNOV)?
What is the 5-year average PE Ratio for MediciNova, Inc. (MNOV)?
How does the current PE Ratio for MediciNova, Inc. (MNOV) compare to its historical average?